815 studies found for:    Alexander Disease
Show Display Options
Rank Status Study
21 Withdrawn Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia
Conditions: Chronic Kidney Disease;   Anemia
Intervention: Drug: Rilonacept
22 Active, not recruiting A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
Conditions: Cardiovascular Disease;   High Cardiovascular Risk;   Obesity;   Overweight;   Type 2 Diabetes
Interventions: Drug: APD356-Lorcaserin hydrochloride;   Drug: Placebo
23 Recruiting Executive Functioning in TBI From Rehabilitation to Social Reintegration: COMPASS
Conditions: Traumatic Brain Injury;   Post-Traumatic Stress Disorder
Interventions: Behavioral: Experimental - COMPASS;   Behavioral: Control - COMPASS
24 Recruiting Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: PF-02545920;   Other: Placebo
25 Not yet recruiting Immunophenotyping From Blood of Patients Suffering From Chronic Degenerating Joint Diseases and Receiving LDRT
Condition: Chronic Inflammatory Disorder
Intervention: Other: Blood Draw and Questionaire
26 Recruiting Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
Condition: Huntington's Disease
Intervention: Drug: 20 mg BID of PF-02545920
27 Recruiting Catheter Placement for Hepatic Hydrothorax
Condition: Pleural Effusion
Intervention: Device: Indwelling tunneled pleural catheter (ITPC)
28 Recruiting Registry for Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases - EXCITING
Condition: Interstitial Lung Disease (ILD)
Intervention:
29 Terminated Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention: Drug: PB127 for Injectable Suspension
30 Terminated
Has Results
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study
Condition: Major Depressive Disorder
Intervention: Drug: SPD489 (Lisdexamfetamine dimesylate) + Antidepressant
31 Completed
Has Results
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate );   Drug: Antidepressant + Placebo
32 Completed Behavioral Activation for Posttraumatic Stress Disorder (PTSD)/ Depression Treatment in Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) Veterans
Conditions: Posttraumatic Stress Disorder;   Depression
Interventions: Behavioral: Behavioral Activation treatment;   Other: Usual VA Treatment for PTSD
33 Completed
Has Results
Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis
Condition: Kidney Failure, Chronic
Interventions: Drug: Placebo;   Drug: Genz-644470;   Drug: Sevelamer carbonate
34 Completed Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety
Conditions: Major Depressive Disorder;   Anxiety
Intervention: Drug: BCI-540
35 Unknown  A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage
Condition: Small Cell Lung Cancer
Intervention: Drug: Carboplatin plus Irinotecan vs Carboplatin plus Etoposide
36 Recruiting A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder
Condition: Autism Spectrum Disorder
Interventions: Drug: IGF-1;   Drug: Placebo/saline
37 Recruiting Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Behavioral: Tai Chi;   Behavioral: Exercise
38 Active, not recruiting Autologous Bone Marrow Mononuclear Cells in the Combined Treatment of Coronary Heart Disease
Condition: Ischemic Heart Disease
Interventions: Procedure: coronary artery bypass grafting with administration of autologous bone marrow stem cells;   Procedure: coronary artery bypass grafting with administration of 0.9 % NaCl (sodium chloride) 0.2 ml
39 Recruiting Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Condition: Non Alcoholic Steatohepatitis (NASH)
Interventions: Drug: Obeticholic Acid;   Drug: Placebo
40 Active, not recruiting Parkinsonics: A Controlled Study of Group Singing in Parkinson Disease
Condition: Parkinson Disease
Interventions: Behavioral: Group singing;   Behavioral: Facilitated Discussion Group

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years